Sanara MedTech to Release 2024 Financial Results Soon
Sanara MedTech Inc. (Nasdaq: SMTI) is preparing to unveil its financial performance for the fourth quarter and full year 2024. On the morning of March 25, 2025, prior to the opening of financial markets, the company will announce the results that reflect its commitment to enhancing clinical outcomes and cost efficiencies in the surgical, chronic wound, and skincare markets.
Join Sanara's Upcoming Conference Call
The company invites stakeholders and interested parties to participate in a conference call scheduled for the same day, at 8:00 a.m. Eastern Time. This session will provide an opportunity for in-depth discussions about the fourth quarter and full year's financial outcomes, followed by a question-and-answer segment. To join, dial 888-506-0062 (international callers can reach them at 973-528-0011) and enter the access code 904042.
If you miss the live discussion, a replay will be available until April 8, 2025, using the same dialing numbers along with the passcode: 52172 for access.
Webcast Access from the Company’s Website
For those who prefer a digital format, Sanara will also provide a live webcast of the conference call accessible via the Investor Relations section of their official website. Following the event, an online replay will be made available, ensuring that anyone can catch up on the insights shared during the call.
Insights Into Sanara MedTech Inc.
Sanara MedTech, dedicated to advancing medical technology, focuses on creating innovative products that deliver significant improvements in clinical outcomes while reducing healthcare costs. The company is known for its diverse portfolio that caters to surgeons and clinicians, delivering excellence in surgical, wound, and skincare products.
Some of their notable offerings in the surgical market include CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix. Simultaneously, they provide advanced solutions in wound care through products like BIAK?S Antimicrobial Skin and Wound Cleanser and Gel. Sanara also emphasizes telemedicine, offering virtual consultations which broaden access to their expertise and products.
Reflecting their commitment to innovation, Sanara maintains a robust pipeline of future products focusing on advancing wound care technology, addressing challenges such as opportunistic pathogens and biofilm management. Their strategic goal centers around forming partnerships that promote products meeting healthcare needs effectively while ensuring affordability.
Continuous Commitment to Excellence and Innovation
At Sanara MedTech, the mission goes beyond just product development. The company aims to transform how care is delivered by consistently seeking out novel approaches to enhance healing processes. Their products are designed not just to perform well but to contribute significantly to cost reductions in healthcare, making them a proactive choice for professionals across the board.
Frequently Asked Questions
What financial results is Sanara MedTech announcing?
Sanara MedTech is set to announce its fourth quarter and full year 2024 financial results.
When will Sanara MedTech hold its conference call?
The conference call will take place on March 25, 2025, at 8:00 a.m. Eastern Time.
How can I access the conference call?
You can join the call by dialing 888-506-0062 or 973-528-0011 for international callers, using the access code 904042.
Where can I find the webcast of the call?
The live webcast will be available in the Investor Relations section of Sanara's official website.
What products does Sanara MedTech offer?
Sanara offers products in surgical care, chronic wound management, and skincare, including CellerateRX and various antimicrobial wound care solutions.
